90 T (Brilinta 90 mg)
Generic Name: ticagrelor
Pill with imprint 90 T is Yellow, Round and has been identified as Brilinta 90 mg. It is supplied by AstraZeneca.
Brilinta is used in the treatment of myocardial infarction, prophylaxis; prevention of atherothrombotic events; heart attack; acute coronary syndrome and belongs to the drug class platelet aggregation inhibitors. Risk cannot be ruled out during pregnancy. Brilinta 90 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 90 T
Brilinta
- Generic Name:
- ticagrelor
- Imprint:
- 90 T
- Strength:
- 90 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- AstraZeneca
- National Drug Code (NDC):
- 00186-0777
More about Brilinta (ticagrelor)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 38 Reviews
- Generic Availability
- Drug class: platelet aggregation inhibitors
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
